Replies to post #18972 on Regen BioPharma Inc (RGBP)

[PeteArjean]

Maybe you are right about that - but what about the share-price - nothing much is happening compared to the news???!!! How come you think??

Regards,

Peter, Denmark

[1~Eye~Jack!!]

~ RGBP = Share Structure = NO CHANGE!!! ;-)

UPDATE = Checked Again 10/13/2015 = NO Changes!!! = As of Sept 9, 2015, as per T/A being called, Regen Biopharma, Inc. only has 114,870,272 common shares issued and outstanding!! ;-)

O/S = 114,870,272
A/S = 500,000,000

RGBP Transfer Agent:
Securities Transfer Corporation

2591 Dallas Parkway Suite 102

Frisco, Texas 75034

Phone - 469-633-0101

FAX [phone]

[1~Eye~Jack!!]

~ RGBP = DiffronC

Myelodysplastic Syndrome Gene Silencing – DiffronC
DiffronC is a novel form of therapy called differentiation therapy that is expected to have much milder toxicity than chemotherapy. The mechanism of action is to correct the specific genes that prevent the myelodysplastic syndrome stem cell from producing mature blood cells.
siRNA silencing of our newly discovered cancer stem cell target gene
Silencing using DiffronC induces differentiation of cancer cells
Initial indication is treatment of myelodysplastic syndrome
Other indications include solid tumors and acute leukemia